Citation Impact
Citing Papers
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
2008 Standout
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
2015 StandoutNobel
Evolutionary history and the effect of biodiversity on plant productivity
2008
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Signal integration in the endoplasmic reticulum unfolded protein response
2007 Standout
EglN2 associates with the NRF 1‐ PGC 1α complex and controls mitochondrial function in breast cancer
2015 StandoutNobel
Molecular imaging of hypoxia with radiolabelled agents
2009
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Reproducibility of quantitative (R)-[11C]verapamil studies
2012
Hallmarks of Cancer: The Next Generation
2011 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Regulation of the Warburg Effect in Early-Passage Breast Cancer Cells
2008
Assessing Tumor Hypoxia in Cervical Cancer by PET with 60Cu-Labeled Diacetyl-Bis(N4-Methylthiosemicarbazone)
2008
Molecular imaging in drug development
2008 Standout
Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development
2007
In vitrokinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals
2009
Targeting hypoxia in cancer therapy
2011 Standout
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
1993
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Cu–ATSM: A radiopharmaceutical for the PET imaging of hypoxia
2007
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
MRI of the tumor microenvironment
2002
Energy metabolism in tumor cells
2007
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Imaging in the era of molecular oncology
2008 StandoutNature
Glioblastoma and Other Malignant Gliomas
2013 Standout
Phaeochromocytoma
2005 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Biodiversity loss and its impact on humanity
2012 StandoutNature
Head and neck cancer
2008 Standout
Reporter gene imaging: potential impact on therapy
2005
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
SDH5 Mutations and Familial Paraganglioma: Somewhere Warburg is Smiling
2009 StandoutNobel
Autoradiographic and small-animal PET comparisons between 18F-FMISO, 18F-FDG, 18F-FLT and the hypoxic selective 64Cu-ATSM in a rodent model of cancer
2008
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
Removal of trace organics by MBR treatment: The role of molecular properties
2011
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
2008
Regulation of cancer cell metabolism
2011 Standout
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
2011
Malignant Gliomas in Adults
2008 Standout
Angiogenesis in brain tumours
2007
New approaches for imaging tumour responses to treatment
2008
Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
2006
Promise and pitfalls of quantitative imaging in oncology clinical trials
2012
Pitfalls in the diagnosis of brain tumours
2006
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Hypoxia and cancer
2007
The role of the unfolded protein response in tumour development: friend or foe?
2004
Microenvironmental regulation of metastasis
2008 Standout
Primary brain tumours in adults
2012 Standout
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
2008
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d -glucose PET
1999
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Ras-dependent carbon metabolism and transformation in mouse fibroblasts
2006
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
2009 StandoutNature
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Clinical Applications of PET in Brain Tumors
2007
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Clues from cell metabolism
2010 StandoutNatureNobel
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Chemical Design and Synthesis of Functionalized Probes for Imaging and Treating Tumor Hypoxia
2017
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Advances in Transition Metal (Pd,Ni,Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners
2011 Standout
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
2006
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Polymers for 3D Printing and Customized Additive Manufacturing
2017 Standout
Evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice.
2004
Synthese von 11C‐, 18F‐, 15O‐ und 13N‐Radiotracern für die Positronenemissionstomographie
2008
PET-based treatment planning in radiotherapy: a new standard?
2007
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Biodistribution and Clearance of Stable Superparamagnetic Maghemite Iron Oxide Nanoparticles in Mice Following Intraperitoneal Administration
2018
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
2015
Imaging the Unfolded Protein Response in Primary Tumors Reveals Microenvironments with Metabolic Variations that Predict Tumor Growth
2009
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
2010 Standout
Toward [18F]-Labeled Aryltrifluoroborate Radiotracers: In Vivo Positron Emission Tomography Imaging of Stable Aryltrifluoroborate Clearance in Mice
2008
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Functional diffusion map: A noninvasive MRI biomarker for early stratification of clinical brain tumor response
2005
FDG-PET and Beyond: Molecular Breast Cancer Imaging
2005
Works of Mark Muzi being referenced
C11-Acetate and F-18 FDG PET for Men With Prostate Cancer Bone Metastases
2011
Deoxyglucose Kinetics in a Rat Brain Tumor
1989
Hypoxia imaging-directed radiation treatment planning
2006
Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans
2009
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy of 3′-Deoxy-3′-[18F]fluorothymidine (FLT) as a Marker of Proliferation in Patients with Recurrent Gliomas: Preliminary Efficacy Studies
2009
Verapamil P-glycoprotein Transport across the Rat Blood-Brain Barrier: Cyclosporine, a Concentration Inhibition Analysis, and Comparison with Human Data
2006
Complementary but Distinct Roles for MRI and18F-Fluoromisonidazole PET in the Assessment of Human Glioblastomas
2008
Positron emission tomography imaging of brain tumors
2003
Quantitative assessment of dynamic PET imaging data in cancer imaging
2012
Determining Hypoxic Fraction in a Rat Glioma by Uptake of Radiolabeled Fluoromisonidazole
2000
Rapid solid-phase extraction method to quantify [11C]-verapamil, and its [11C]-metabolites, in human and macaque plasma
2008
Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging
2015
True tracers: comparing FDG with glucose and FLT with thymidine
2005
[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: Clinical outcomes and patterns of failure
2005
An adaptation of ridge regression for improved estimation of kinetic model parameters from PET studies
2005
Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival
2008
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
2007
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.
2002
PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake
2011
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
1998
18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.
2004
Hypoxia and Glucose Metabolism in Malignant Tumors
2004
Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
2006